Delivery Order SPE2DB20D1100-SPE2DB25FE0GU
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,041.80 to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of VEVYE 0.1% eye drop solution in 2ML units. This is a firm fixed-price delivery order with an ultimate completion date of September 29, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside designation, reflecting AmerisourceBergen's capability to compete in...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,100.31 to AmerisourceBergen Drug Corp for the supply of Vevye 0.1% eye drop in 2ML units. This firm fixed-price delivery order, issued on August 15, 2025, with an ultimate completion date of August 18, 2025, represents a non-competitive award under an existing contract vehicle. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,047.98 for VEVYE 0.1% eye drop solution (2ml) on September 25, 2025, with completion scheduled for September 26, 2025. This firm fixed-price contract represents a non-competitive, non-set-aside award and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical vendor for federal...
- The Defense Logistics Agency (DLA) awarded a $4,116.93 firm fixed price delivery order to AmerisourceBergen Drug Corp for Vevye 0.1% eye drop solution (2mL) on July 17, 2025, with an ultimate completion date of July 18, 2025. The award was made on a competitive basis with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and will perform the work at its corporate office location. This delivery order represents a child...
- The Defense Logistics Agency awarded a $1,765.59 firm fixed-price delivery order to AmerisourceBergen Drug Corp for VEVYE 0.1% eye drop solution (2ML) on July 21, 2025, with completion expected by July 22, 2025. This non-set-aside contract represents a child delivery order issued under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion global pharmaceutical support vehicle running through December 2026. The product will be...
- The Defense Logistics Agency awarded a $1,571.97 delivery order to AmerisourceBergen Drug Corp for VEVYE 0.1% eye drop (2ML) on September 26, 2025, with completion scheduled for September 29, 2025. This firm fixed-price contract was competitively awarded with no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal medical procurement vendor that...
- The Defense Logistics Agency awarded a delivery order valued at $10,103.46 to AmerisourceBergen Drug Corp for VEVYE 0.1% eye drop solution (2ML) on September 8, 2025, with completion scheduled for September 9, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $2,653.69 to AmerisourceBergen Drug Corp for VEVYE 0.1% eye drop solution (2mL) under a firm fixed price contract with an ultimate completion date of July 31, 2025. The award was made on July 30, 2025, without set-aside designation, indicating competitive procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this delivery order at its corporate office location. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $1,047.98 to AmerisourceBergen Drug Corp for VEVYE 0.1% Eye Drop (2mL) on July 28, 2025, with an ultimate completion date of July 29, 2025. This firm fixed-price, competitively awarded delivery order represents a small-value pharmaceutical procurement executed through AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime contract vehicle running through December...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for VEVYE 0.1% Eye Drop (2ML) with a ceiling value of $2,509.24. This firm fixed price delivery order was competitively awarded without set-aside provisions and is scheduled for completion by September 18, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's Indefinite Delivery Contract (IDC)...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FE0GUDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,519.02 to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Vevye 0.1% eye drop solution (2ML units). This is a firm fixed-price, competitively awarded contract with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with a completion date of September 18, 2025. This delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999 prime vendor agreement running through December 2026 that serves as the primary vehicle for pharmaceutical and medical supply support to military healthcare systems. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, maintains an extensive federal contract portfolio with DLA and supports critical medical procurement across the Defense Health Agency and other federal healthcare systems. The company's federal contract awards demonstrate capability in delivering a comprehensive range of pharmaceutical products, including specialty medications, brand-name and generic drugs, and medical supplies across multiple therapeutic domains. This small-value eye drop delivery represents routine pharmaceutical supply fulfillment within the broader scope of AmerisourceBergen's established role as a key vendor for federal military and veteran healthcare needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.5k | 9/17/25 |